Cargando…
Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney disease
Polycystic kidney disease (PKD) is a significant cause of end-stage kidney failure and there are few effective drugs for treating this inherited condition. Numerous aberrantly expressed non-coding RNAs (ncRNAs), particularly microRNAs (miRNAs), may contribute to PKD pathogenesis by participating in...
Autores principales: | Zheng, Qi, Reid, Glen, Eccles, Michael R., Stayner, Cherie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531119/ https://www.ncbi.nlm.nih.gov/pubmed/36203940 http://dx.doi.org/10.3389/fphys.2022.1006427 |
Ejemplares similares
-
Polycystic kidney disease – where gene dosage counts
por: Eccles, Michael R., et al.
Publicado: (2014) -
Recent Discoveries in Epigenetic Modifications of Polycystic Kidney Disease
por: Bowden, Sarah A., et al.
Publicado: (2021) -
Gastric juice non-coding RNAs as potential biomarkers for gastric cancer
por: Gareev, Ilgiz, et al.
Publicado: (2023) -
Kidney diseases and long non-coding RNAs in the limelight
por: Liu, Chenxin, et al.
Publicado: (2022) -
Non-Coding RNAs in Sepsis-Associated Acute Kidney Injury
por: Chen, Yanna, et al.
Publicado: (2022)